Trial Profile
Phase I drug-drug interaction (DDI) study evaluating the effects of sovaprevir + ritonavir-boosted atazanavir in healthy subjects
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 02 Oct 2013
Price :
$35
*
At a glance
- Drugs Sovaprevir (Primary) ; Atazanavir/ritonavir
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 02 Oct 2013 New trial record